A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo

Suping Li, Qiao Jiang, Shaoli Liu, Yinlong Zhang, Yanhua Tian, Chen Song, Jing Wang, Yiguo Zou, Gregory J. Anderson, Jing Yan Han, Yung Chang, Yan Liu, Chen Zhang, Liang Chen, Guangbiao Zhou, Guangjun Nie, Hao Yan, Baoquan Ding, Yuliang Zhao

Research output: Contribution to journalArticle

152 Citations (Scopus)

Abstract

Nanoscale robots have potential as intelligent drug delivery systems that respond to molecular triggers. Using DNA origami we constructed an autonomous DNA robot programmed to transport payloads and present them specifically in tumors. Our nanorobot is functionalized on the outside with a DNA aptamer that binds nucleolin, a protein specifically expressed on tumor-associated endothelial cells, and the blood coagulation protease thrombin within its inner cavity. The nucleolin-targeting aptamer serves both as a targeting domain and as a molecular trigger for the mechanical opening of the DNA nanorobot. The thrombin inside is thus exposed and activates coagulation at the tumor site. Using tumor-bearing mouse models, we demonstrate that intravenously injected DNA nanorobots deliver thrombin specifically to tumor-associated blood vessels and induce intravascular thrombosis, resulting in tumor necrosis and inhibition of tumor growth. The nanorobot proved safe and immunologically inert in mice and Bama miniature pigs. Our data show that DNA nanorobots represent a promising strategy for precise drug delivery in cancer therapy.

Original languageEnglish (US)
Pages (from-to)258-264
Number of pages7
JournalNature Biotechnology
Volume36
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Nanorobots
Tumors
DNA
Neoplasms
Thrombin
Coagulation
Therapeutics
Bearings (structural)
Robots
Nucleotide Aptamers
Vascular Tissue Neoplasms
Endothelial cells
Blood vessels
Blood Coagulation
Drug Delivery Systems
Drug delivery
Thrombosis
Blood
Peptide Hydrolases
Necrosis

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology
  • Molecular Medicine
  • Biomedical Engineering

Cite this

Li, S., Jiang, Q., Liu, S., Zhang, Y., Tian, Y., Song, C., ... Zhao, Y. (2018). A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo. Nature Biotechnology, 36(3), 258-264. https://doi.org/10.1038/nbt.4071

A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo. / Li, Suping; Jiang, Qiao; Liu, Shaoli; Zhang, Yinlong; Tian, Yanhua; Song, Chen; Wang, Jing; Zou, Yiguo; Anderson, Gregory J.; Han, Jing Yan; Chang, Yung; Liu, Yan; Zhang, Chen; Chen, Liang; Zhou, Guangbiao; Nie, Guangjun; Yan, Hao; Ding, Baoquan; Zhao, Yuliang.

In: Nature Biotechnology, Vol. 36, No. 3, 01.03.2018, p. 258-264.

Research output: Contribution to journalArticle

Li, S, Jiang, Q, Liu, S, Zhang, Y, Tian, Y, Song, C, Wang, J, Zou, Y, Anderson, GJ, Han, JY, Chang, Y, Liu, Y, Zhang, C, Chen, L, Zhou, G, Nie, G, Yan, H, Ding, B & Zhao, Y 2018, 'A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo', Nature Biotechnology, vol. 36, no. 3, pp. 258-264. https://doi.org/10.1038/nbt.4071
Li, Suping ; Jiang, Qiao ; Liu, Shaoli ; Zhang, Yinlong ; Tian, Yanhua ; Song, Chen ; Wang, Jing ; Zou, Yiguo ; Anderson, Gregory J. ; Han, Jing Yan ; Chang, Yung ; Liu, Yan ; Zhang, Chen ; Chen, Liang ; Zhou, Guangbiao ; Nie, Guangjun ; Yan, Hao ; Ding, Baoquan ; Zhao, Yuliang. / A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo. In: Nature Biotechnology. 2018 ; Vol. 36, No. 3. pp. 258-264.
@article{45003733f64e44fa9909c737b85c0c99,
title = "A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo",
abstract = "Nanoscale robots have potential as intelligent drug delivery systems that respond to molecular triggers. Using DNA origami we constructed an autonomous DNA robot programmed to transport payloads and present them specifically in tumors. Our nanorobot is functionalized on the outside with a DNA aptamer that binds nucleolin, a protein specifically expressed on tumor-associated endothelial cells, and the blood coagulation protease thrombin within its inner cavity. The nucleolin-targeting aptamer serves both as a targeting domain and as a molecular trigger for the mechanical opening of the DNA nanorobot. The thrombin inside is thus exposed and activates coagulation at the tumor site. Using tumor-bearing mouse models, we demonstrate that intravenously injected DNA nanorobots deliver thrombin specifically to tumor-associated blood vessels and induce intravascular thrombosis, resulting in tumor necrosis and inhibition of tumor growth. The nanorobot proved safe and immunologically inert in mice and Bama miniature pigs. Our data show that DNA nanorobots represent a promising strategy for precise drug delivery in cancer therapy.",
author = "Suping Li and Qiao Jiang and Shaoli Liu and Yinlong Zhang and Yanhua Tian and Chen Song and Jing Wang and Yiguo Zou and Anderson, {Gregory J.} and Han, {Jing Yan} and Yung Chang and Yan Liu and Chen Zhang and Liang Chen and Guangbiao Zhou and Guangjun Nie and Hao Yan and Baoquan Ding and Yuliang Zhao",
year = "2018",
month = "3",
day = "1",
doi = "10.1038/nbt.4071",
language = "English (US)",
volume = "36",
pages = "258--264",
journal = "Biotechnology",
issn = "1087-0156",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo

AU - Li, Suping

AU - Jiang, Qiao

AU - Liu, Shaoli

AU - Zhang, Yinlong

AU - Tian, Yanhua

AU - Song, Chen

AU - Wang, Jing

AU - Zou, Yiguo

AU - Anderson, Gregory J.

AU - Han, Jing Yan

AU - Chang, Yung

AU - Liu, Yan

AU - Zhang, Chen

AU - Chen, Liang

AU - Zhou, Guangbiao

AU - Nie, Guangjun

AU - Yan, Hao

AU - Ding, Baoquan

AU - Zhao, Yuliang

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Nanoscale robots have potential as intelligent drug delivery systems that respond to molecular triggers. Using DNA origami we constructed an autonomous DNA robot programmed to transport payloads and present them specifically in tumors. Our nanorobot is functionalized on the outside with a DNA aptamer that binds nucleolin, a protein specifically expressed on tumor-associated endothelial cells, and the blood coagulation protease thrombin within its inner cavity. The nucleolin-targeting aptamer serves both as a targeting domain and as a molecular trigger for the mechanical opening of the DNA nanorobot. The thrombin inside is thus exposed and activates coagulation at the tumor site. Using tumor-bearing mouse models, we demonstrate that intravenously injected DNA nanorobots deliver thrombin specifically to tumor-associated blood vessels and induce intravascular thrombosis, resulting in tumor necrosis and inhibition of tumor growth. The nanorobot proved safe and immunologically inert in mice and Bama miniature pigs. Our data show that DNA nanorobots represent a promising strategy for precise drug delivery in cancer therapy.

AB - Nanoscale robots have potential as intelligent drug delivery systems that respond to molecular triggers. Using DNA origami we constructed an autonomous DNA robot programmed to transport payloads and present them specifically in tumors. Our nanorobot is functionalized on the outside with a DNA aptamer that binds nucleolin, a protein specifically expressed on tumor-associated endothelial cells, and the blood coagulation protease thrombin within its inner cavity. The nucleolin-targeting aptamer serves both as a targeting domain and as a molecular trigger for the mechanical opening of the DNA nanorobot. The thrombin inside is thus exposed and activates coagulation at the tumor site. Using tumor-bearing mouse models, we demonstrate that intravenously injected DNA nanorobots deliver thrombin specifically to tumor-associated blood vessels and induce intravascular thrombosis, resulting in tumor necrosis and inhibition of tumor growth. The nanorobot proved safe and immunologically inert in mice and Bama miniature pigs. Our data show that DNA nanorobots represent a promising strategy for precise drug delivery in cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=85042935014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042935014&partnerID=8YFLogxK

U2 - 10.1038/nbt.4071

DO - 10.1038/nbt.4071

M3 - Article

C2 - 29431737

AN - SCOPUS:85042935014

VL - 36

SP - 258

EP - 264

JO - Biotechnology

JF - Biotechnology

SN - 1087-0156

IS - 3

ER -